Physician profile
Eric P Teplitz
NPI 1871526343
$2,619.36
in general payments reported to CMS, 2019-2025
21 companies · $55.70 in 2025
The $55.70 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $339 · 2021: $608 · 2022: $214 · 2023: $209 · 2024: $157 · 2025: $55.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $463.81 | 2019-2024 | Xarelto, Spravato |
| Amarin Pharma, INC. | $321.92 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $274.64 | 2019-2021 | |
| Pfizer INC. | $205.25 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $196.56 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $165.89 | 2019-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.54 | 2019-2025 | Lifevest |
| Amgen INC. | $151.53 | 2019-2024 | Repatha |
| Kowa Pharmaceuticals America, INC. | $121.02 | 2019-2021 | |
| Esperion Therapeutics, INC. | $112.43 | 2021-2025 | Nexletol |
| Edwards Lifesciences Corporation | $92.31 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi-Aventis U.S. LLC | $74.11 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $67.44 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.94 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.18 | 2023 | Vpriv |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $25.28 | 2023 | |
| Allergan, INC. | $24.74 | 2019 | |
| Exact Sciences Corporation | $22.14 | 2024 | Cologuard Collection Kit |
| Lantheus Medical Imaging, INC. | $21.20 | 2022 | |
| Abbott Laboratories | $18.37 | 2022 | |
| Lilly USA, LLC | $15.06 | 2024 | Mounjaro, Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Teplitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.